scispace - formally typeset
G

Giorgio Gallinella

Researcher at University of Bologna

Publications -  108
Citations -  2470

Giorgio Gallinella is an academic researcher from University of Bologna. The author has contributed to research in topics: Parvovirus & Hybridization probe. The author has an hindex of 28, co-authored 100 publications receiving 2225 citations.

Papers
More filters
Journal ArticleDOI

Parvovirus B19 clearance from peripheral blood after acute infection.

TL;DR: One patient showed a persistent infection associated with chronic arthritis and was positive for B19 DNA for 1 year without clearance of the virus, followed after acute infection to determine how long the virus is present in blood, even at low titer.
Journal ArticleDOI

Bone marrow necrosis and fat embolism syndrome in sickle cell disease: increased susceptibility of patients with non-SS genotypes and a possible association with human parvovirus B19 infection.

TL;DR: Patients most at risk appear to be those with a "milder" form of SCD as 81% of patients had a genotype other than HbSS and the majority had no history of significant sickle-related complications.
Journal ArticleDOI

Distribution and viral load of type specific HPVs in different cervical lesions as detected by PCR-ELISA

TL;DR: Investigating the distribution and viral load of the most prevalent high risk human papillomavirus types 16, 18, 31, 33, and 45 and low risk HPV types 6 and 11 in a variety of cervical lesions showed that only HPV-16 DNA could reach very high values and a very high HPV- 16 load correlated with the severity of cervical disease.
Journal ArticleDOI

Nested polymerase chain reaction assay for the detection of B19 parvovirus DNA in human immunodeficiency virus patients

TL;DR: The study shows that, in the presence of specific B19 IgM, circulating virus may still be present but can be detected only by PCR, the only method for virus detection.
Journal ArticleDOI

Diagnosis and quantitative evaluation of parvovirus B19 infections by real-time PCR in the clinical laboratory.

TL;DR: The high levels of sensitivity, specificity, and rapidity provided by the LightCycler technology for the detection and quantitation of B 19 DNA represent a significant improvement for the laboratory diagnosis of B19 infection.